These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 25333435)

  • 1. Attributable inpatient costs of recurrent Clostridium difficile infections.
    Dubberke ER; Schaefer E; Reske KA; Zilberberg M; Hollenbeak CS; Olsen MA
    Infect Control Hosp Epidemiol; 2014 Nov; 35(11):1400-7. PubMed ID: 25333435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recurrent Clostridium difficile infection is associated with increased mortality.
    Olsen MA; Yan Y; Reske KA; Zilberberg MD; Dubberke ER
    Clin Microbiol Infect; 2015 Feb; 21(2):164-70. PubMed ID: 25658560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Clostridium difficile recurrence on hospital readmissions.
    Olsen MA; Yan Y; Reske KA; Zilberberg M; Dubberke ER
    Am J Infect Control; 2015 Apr; 43(4):318-22. PubMed ID: 25690876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hospital cost of Clostridium difficile infection including the contribution of recurrences in French acute-care hospitals.
    Le Monnier A; Duburcq A; Zahar JR; Corvec S; Guillard T; Cattoir V; Woerther PL; Fihman V; Lalande V; Jacquier H; Mizrahi A; Farfour E; Morand P; Marcadé G; Coulomb S; Torreton E; Fagnani F; Barbut F;
    J Hosp Infect; 2015 Oct; 91(2):117-22. PubMed ID: 26253518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short- and long-term attributable costs of Clostridium difficile-associated disease in nonsurgical inpatients.
    Dubberke ER; Reske KA; Olsen MA; McDonald LC; Fraser VJ
    Clin Infect Dis; 2008 Feb; 46(4):497-504. PubMed ID: 18197759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiology and healthcare costs of incident Clostridium difficile infections identified in the outpatient healthcare setting.
    Kuntz JL; Johnson ES; Raebel MA; Petrik AF; Yang X; Thorp ML; Spindel SJ; Neil N; Smith DH
    Infect Control Hosp Epidemiol; 2012 Oct; 33(10):1031-8. PubMed ID: 22961023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular epidemiology of Clostridium difficile infections in children: a retrospective cohort study.
    Kociolek LK; Patel SJ; Shulman ST; Gerding DN
    Infect Control Hosp Epidemiol; 2015 Apr; 36(4):445-51. PubMed ID: 25782900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Economic burden of primary compared with recurrent Clostridium difficile infection in hospitalized patients: a prospective cohort study.
    Shah DN; Aitken SL; Barragan LF; Bozorgui S; Goddu S; Navarro ME; Xie Y; DuPont HL; Garey KW
    J Hosp Infect; 2016 Jul; 93(3):286-9. PubMed ID: 27209056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of Clostridium difficile isolates from individuals with recurrent and single episode of infection.
    Richardson C; Kim P; Lee C; Bersenas A; Weese JS
    Anaerobe; 2015 Jun; 33():105-8. PubMed ID: 25769665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inpatient Expenditures Attributable to Hospital-Onset Clostridium difficile Infection: A Nationwide Case-Control Study in Japan.
    Fukuda H; Yano T; Shimono N
    Pharmacoeconomics; 2018 Nov; 36(11):1367-1376. PubMed ID: 30022364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiological and economic burden of Clostridium difficile in the United States: estimates from a modeling approach.
    Desai K; Gupta SB; Dubberke ER; Prabhu VS; Browne C; Mast TC
    BMC Infect Dis; 2016 Jun; 16():303. PubMed ID: 27316794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Excess Length of Stay Attributable to Clostridium difficile Infection (CDI) in the Acute Care Setting: A Multistate Model.
    Stevens VW; Khader K; Nelson RE; Jones M; Rubin MA; Brown KA; Evans ME; Greene T; Slade E; Samore MH
    Infect Control Hosp Epidemiol; 2015 Sep; 36(9):1024-30. PubMed ID: 26006153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clostridium difficile recurrence is a strong predictor of 30-day rehospitalization among patients in intensive care.
    Zilberberg MD; Shorr AF; Micek ST; Kollef MH
    Infect Control Hosp Epidemiol; 2015 Mar; 36(3):273-9. PubMed ID: 25695168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of hospital-acquired Clostridium difficile.
    Lipp MJ; Nero DC; Callahan MA
    J Gastroenterol Hepatol; 2012 Nov; 27(11):1733-7. PubMed ID: 22849881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vital signs: preventing Clostridium difficile infections.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2012 Mar; 61(9):157-62. PubMed ID: 22398844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An antimicrobial stewardship program's real-world experience with fidaxomicin for treatment of Clostridium difficile infection: a case series.
    Vargo CA; Bauer KA; Mangino JE; Johnston JE; Goff DA
    Pharmacotherapy; 2014 Sep; 34(9):901-9. PubMed ID: 24898525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term follow-up of colonoscopic fecal microbiota transplant for recurrent Clostridium difficile infection.
    Brandt LJ; Aroniadis OC; Mellow M; Kanatzar A; Kelly C; Park T; Stollman N; Rohlke F; Surawicz C
    Am J Gastroenterol; 2012 Jul; 107(7):1079-87. PubMed ID: 22450732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trend, Risk Factors, and Costs of Clostridium difficile Infections in Vascular Surgery.
    Egorova NN; Siracuse JJ; McKinsey JF; Nowygrod R
    Ann Vasc Surg; 2015; 29(4):792-800. PubMed ID: 25595110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors and burden of hospital readmission with recurrent Clostridioides difficile infection: a French nation-wide inception cohort study.
    Dinh A; Le Monnier A; Emery C; Alami S; Torreton É; Duburcq A; Barbier F
    Eur J Clin Microbiol Infect Dis; 2019 Jul; 38(7):1297-1305. PubMed ID: 30941532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Attributable Healthcare Resource Utilization and Costs for Patients With Primary and Recurrent Clostridium difficile Infection in the United States.
    Zhang D; Prabhu VS; Marcella SW
    Clin Infect Dis; 2018 Apr; 66(9):1326-1332. PubMed ID: 29360950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.